Skip to main content

Adenotonsillectomy No Aid for Neurodevelopmental Outcomes in Children

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 9, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 8, 2023 -- In children with mild sleep-disordered breathing (SDB), adenotonsillectomy does not significantly improve executive function or attention, according to a study published in the Dec. 5 issue of the Journal of the American Medical Association.

Susan Redline, M.D., from Brigham and Women’s Hospital in Boston, and colleagues compared early adenotonsillectomy versus watchful waiting and supportive care (watchful waiting) on neurodevelopmental, behavioral, health, and polysomnographic outcomes among children with mild SDB. The analysis included 459 children (aged 3 to 12.9 years) with snoring and an obstructive apnea-hypopnea index (AHI) <3 (394 with 12-month follow-up).

The researchers found that at 12 months, there were no statistically significant differences in change from baseline between the groups for executive function or attention, but behavioral problems, sleepiness, symptoms, and quality of life each improved more with adenotonsillectomy versus watchful waiting. There was an association between adenotonsillectomy and greater 12-month decline in systolic and diastolic blood pressure percentile levels (difference in changes, −9.02 and −6.52, respectively). Additionally, adenotonsillectomy was associated with less progression of the AHI to greater than three events/hour (1.3 percent of children in the adenotonsillectomy group versus 13.2 percent in the watchful waiting group; difference, −11.2 percent). Adenotonsillectomy was associated with a serious adverse event in six children (2.7 percent).

"These findings do not provide support for adenotonsillectomy in children with mild SDB with the goal of improving cognition, although it is possible that differences may have been observed with additional follow-up," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...

Pediatric Surgical Opioid Prescribing Concentrated Among a Few Procedures

WEDNESDAY, June 26, 2024 -- Pediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a...

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.